Viatris Operating Income 2010-2025 | VTRS

Viatris annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Viatris operating income for the quarter ending March 31, 2025 was $-2.882B, a 1513.54% decline year-over-year.
  • Viatris operating income for the twelve months ending March 31, 2025 was $-3.076B, a 639.37% decline year-over-year.
  • Viatris annual operating income for 2024 was $0.01B, a 98.68% decline from 2023.
  • Viatris annual operating income for 2023 was $0.766B, a 52.55% decline from 2022.
  • Viatris annual operating income for 2022 was $1.615B, a 4849.98% decline from 2021.
Viatris Annual Operating Income
(Millions of US $)
2024 $10
2023 $766
2022 $1,615
2021 $-34
2020 $-211
2019 $716
2018 $906
2017 $1,437
2016 $699
2015 $1,461
2014 $1,353
2013 $1,136
2012 $1,109
2011 $1,005
2010 $722
2009 $523
Viatris Quarterly Operating Income
(Millions of US $)
2025-03-31 $-2,882
2024-12-31 $-180
2024-09-30 $226
2024-06-30 $-240
2024-03-31 $204
2023-12-31 $-455
2023-09-30 $452
2023-06-30 $369
2023-03-31 $400
2022-12-31 $-201
2022-09-30 $560
2022-06-30 $549
2022-03-31 $707
2021-12-31 $-78
2021-09-30 $358
2021-06-30 $-48
2021-03-31 $-266
2020-12-31 $-881
2020-09-30 $351
2020-06-30 $134
2020-03-31 $185
2019-12-31 $272
2019-09-30 $324
2019-06-30 $96
2019-03-31 $24
2018-12-31 $233
2018-09-30 $338
2018-06-30 $179
2018-03-31 $156
2017-12-31 $419
2017-09-30 $317
2017-06-30 $474
2017-03-31 $228
2016-12-31 $313
2016-09-30 $-131
2016-06-30 $411
2016-03-31 $106
2015-12-31 $424
2015-09-30 $601
2015-06-30 $277
2015-03-31 $159
2014-12-31 $393
2014-09-30 $495
2014-06-30 $226
2014-03-31 $239
2013-12-31 $273
2013-09-30 $340
2013-06-30 $309
2013-03-31 $214
2012-12-31 $263
2012-09-30 $335
2012-06-30 $261
2012-03-31 $251
2011-12-31 $247
2011-09-30 $266
2011-06-30 $280
2011-03-31 $212
2010-12-31 $94
2010-09-30 $234
2010-06-30 $195
2010-03-31 $199
2009-12-31 $60
2009-09-30 $61
2009-06-30 $175
2009-03-31 $227
Sector Industry Market Cap Revenue
Medical Medical Services $10.868B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.621B 26.94
CVS Health (CVS) United States $84.680B 10.52
Elevance Health (ELV) United States $78.955B 10.19
Cencora (COR) United States $57.765B 20.10
DiDi Global (DIDIY) China $23.297B 24.75
Natera (NTRA) United States $21.640B 0.00
Labcorp Holdings (LH) United States $21.549B 17.48
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.690B 0.00
Solventum (SOLV) United States $12.990B 13.75
CochLear (CHEOY) Australia $12.847B 0.00
ICON (ICLR) Ireland $12.241B 11.38
Revvity (RVTY) United States $11.865B 20.42
Avantor (AVTR) United States $9.370B 13.61
Medpace Holdings (MEDP) United States $9.269B 24.62
HealthEquity (HQY) United States $8.917B 39.06
Sonic Healthcare (SKHHY) Australia $8.417B 0.00
Charles River Laboratories (CRL) United States $7.779B 15.24
Caris Life Sciences,�Inc (CAI) United States $6.688B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.952B 29.17
BrightSpring Health Services (BTSG) United States $3.769B 34.58
Sotera Health (SHC) United States $3.290B 18.69
Surgery Partners (SGRY) United States $2.853B 37.10
Alignment Healthcare (ALHC) United States $2.712B 0.00
Concentras Parent (CON) United States $2.615B 15.11
Organon (OGN) United States $2.587B 2.75
GeneDx Holdings (WGS) United States $2.432B 93.65
Progyny (PGNY) United States $2.080B 45.79
PACS (PACS) United States $1.972B 0.00
Ardent Health (ARDT) United States $1.970B 8.40
Premier (PINC) United States $1.805B 13.70
GoodRx Holdings (GDRX) United States $1.729B 34.57
Teladoc Health (TDOC) United States $1.493B 0.00
Establishment Labs Holdings (ESTA) $1.271B 0.00
Pediatrix Medical (MD) United States $1.159B 8.82
CareDx (CDNA) United States $1.072B 16.74
Agilon Health (AGL) United States $0.989B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
Nutex Health (NUTX) United States $0.766B 11.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.610B 4.11
InnovAge Holding (INNV) United States $0.574B 0.00
LifeMD (LFMD) United States $0.544B 0.00
SBC Medicals (SBC) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
Auna S.A (AUNA) Luxembourg $0.465B 10.47
Omada Health (OMDA) $0.450B 0.00
So-Young (SY) China $0.423B 0.00
Enhabit (EHAB) United States $0.370B 30.42
Performant Healthcare (PHLT) United States $0.333B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.324B 0.00
Beauty Health (SKIN) United States $0.265B 0.00
Oncology Institute (TOI) United States $0.223B 0.00
DocGo (DCGO) United States $0.158B 25.83
Pheton Holdings (PTHL) China $0.128B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
KindlyMD (NAKA) United States $0.078B 0.00
IceCure Medical (ICCM) Israel $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.055B 0.00
Biodesix (BDSX) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Basel Medical Group (BMGL) Singapore $0.034B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00